Literature DB >> 19212391

Diagnostics: The prostate-cancer metabolome.

Cory Abate-Shen, Michael M Shen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19212391     DOI： 10.1038/457799a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  9 in total

Review 1.  Metabolic profiles of cancer cells.

Authors:  Julian L Griffin; John P Shockcor
Journal:  Nat Rev Cancer       Date:  2004-07       Impact factor: 60.716

2.  An integrated functional genomics and metabolomics approach for defining poor prognosis in human neuroendocrine cancers.

Authors:  Joseph E Ippolito; Jian Xu; Sanjay Jain; Krista Moulder; Steven Mennerick; Jan R Crowley; R Reid Townsend; Jeffrey I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-05       Impact factor: 11.205

3.  The polycomb group protein EZH2 is involved in progression of prostate cancer.

Authors:  Sooryanarayana Varambally; Saravana M Dhanasekaran; Ming Zhou; Terrence R Barrette; Chandan Kumar-Sinha; Martin G Sanda; Debashis Ghosh; Kenneth J Pienta; Richard G A B Sewalt; Arie P Otte; Mark A Rubin; Arul M Chinnaiyan
Journal:  Nature       Date:  2002-10-10       Impact factor: 49.962

4.  Haplotypes, loss of heterozygosity, and expression levels of glycine N-methyltransferase in prostate cancer.

Authors:  Yu-Chuen Huang; Cheng-Ming Lee; Marcelo Chen; Ming-Yi Chung; Yen-Hwa Chang; William Ji-Shian Huang; Donald Ming-Tak Ho; Chin-Chen Pan; Tony T Wu; Stone Yang; Ming-Wei Lin; Jer-Tsong Hsieh; Yi-Ming Arthur Chen
Journal:  Clin Cancer Res       Date:  2007-03-01       Impact factor: 12.531

5.  A comprehensive urinary metabolomic approach for identifying kidney cancerr.

Authors:  Tobias Kind; Vladimir Tolstikov; Oliver Fiehn; Robert H Weiss
Journal:  Anal Biochem       Date:  2007-01-26       Impact factor: 3.365

Review 6.  Clinical applications of metabolomics in oncology: a review.

Authors:  Jennifer L Spratlin; Natalie J Serkova; S Gail Eckhardt
Journal:  Clin Cancer Res       Date:  2009-01-15       Impact factor: 12.531

7.  Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression.

Authors:  Arun Sreekumar; Laila M Poisson; Thekkelnaycke M Rajendiran; Amjad P Khan; Qi Cao; Jindan Yu; Bharathi Laxman; Rohit Mehra; Robert J Lonigro; Yong Li; Mukesh K Nyati; Aarif Ahsan; Shanker Kalyana-Sundaram; Bo Han; Xuhong Cao; Jaeman Byun; Gilbert S Omenn; Debashis Ghosh; Subramaniam Pennathur; Danny C Alexander; Alvin Berger; Jeffrey R Shuster; John T Wei; Sooryanarayana Varambally; Christopher Beecher; Arul M Chinnaiyan
Journal:  Nature       Date:  2009-02-12       Impact factor: 49.962

8.  Loss of the glycine N-methyltransferase gene leads to steatosis and hepatocellular carcinoma in mice.

Authors:  M Luz Martínez-Chantar; Mercedes Vázquez-Chantada; Usue Ariz; Nuria Martínez; Marta Varela; Zigmund Luka; Antonieta Capdevila; Juan Rodríguez; Ana M Aransay; Rune Matthiesen; Heping Yang; Diego F Calvisi; Manel Esteller; Mario Fraga; Shelly C Lu; Conrad Wagner; José M Mato
Journal:  Hepatology       Date:  2008-04       Impact factor: 17.425

9.  Metabolite profiling of human colon carcinoma--deregulation of TCA cycle and amino acid turnover.

Authors:  Carsten Denkert; Jan Budczies; Wilko Weichert; Gert Wohlgemuth; Martin Scholz; Tobias Kind; Silvia Niesporek; Aurelia Noske; Anna Buckendahl; Manfred Dietel; Oliver Fiehn
Journal:  Mol Cancer       Date:  2008-09-18       Impact factor: 27.401
  9 in total
  19 in total

1.  Transcriptional and metabolic data integration and modeling for identification of active pathways.

Authors:  Alexandra Jauhiainen; Olle Nerman; George Michailidis; Rebecka Jörnsten
Journal:  Biostatistics       Date:  2012-06-14       Impact factor: 5.899

Review 2.  Metabolomics as a key integrator for "omic" advancement of personalized medicine and future therapies.

Authors:  Andrea D Eckhart; Kirk Beebe; Mike Milburn
Journal:  Clin Transl Sci       Date:  2012-06       Impact factor: 4.689

Review 3.  Advances in NMR-based biofluid analysis and metabolite profiling.

Authors:  Shucha Zhang; G A Nagana Gowda; Tao Ye; Daniel Raftery
Journal:  Analyst       Date:  2010-04-09       Impact factor: 4.616

4.  Metabolomics: a novel approach to early and noninvasive prostate cancer detection.

Authors:  Matthew J Roberts; Horst J Schirra; Martin F Lavin; Robert A Gardiner
Journal:  Korean J Urol       Date:  2011-02-19

5.  Metabolic imbalance and prostate cancer progression.

Authors:  Anya J Burton; Kate M Tilling; Jeff M Holly; Freddie C Hamdy; Mari-Anne E Rowlands; Jenny L Donovan; Richard M Martin
Journal:  Int J Mol Epidemiol Genet       Date:  2010-07-25

6.  Deep Mining from Omics Data.

Authors:  Abeer Alzubaidi; Jonathan Tepper
Journal:  Methods Mol Biol       Date:  2022

7.  Metabolomics in epidemiology: sources of variability in metabolite measurements and implications.

Authors:  Joshua N Sampson; Simina M Boca; Xiao Ou Shu; Rachael Z Stolzenberg-Solomon; Charles E Matthews; Ann W Hsing; Yu Ting Tan; Bu-Tian Ji; Wong-Ho Chow; Qiuyin Cai; Da Ke Liu; Gong Yang; Yong Bing Xiang; Wei Zheng; Rashmi Sinha; Amanda J Cross; Steven C Moore
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-02-08       Impact factor: 4.254

8.  Identification of phosphatidylcholine and lysophosphatidylcholine as novel biomarkers for cervical cancers in a prospective cohort study.

Authors:  Ming-Zhu Yin; Shu Tan; Xia Li; Yan Hou; Guosheng Cao; Kang Li; Junping Kou; Ge Lou
Journal:  Tumour Biol       Date:  2015-11-13

9.  The role of sarcosine metabolism in prostate cancer progression.

Authors:  Amjad P Khan; Thekkelnaycke M Rajendiran; Bushra Ateeq; Irfan A Asangani; Jyoti N Athanikar; Anastasia K Yocum; Rohit Mehra; Javed Siddiqui; Ganesh Palapattu; John T Wei; George Michailidis; Arun Sreekumar; Arul M Chinnaiyan
Journal:  Neoplasia       Date:  2013-05       Impact factor: 5.715

10.  Assessment of metabolome annotation quality: a method for evaluating the false discovery rate of elemental composition searches.

Authors:  Fumio Matsuda; Yoko Shinbo; Akira Oikawa; Masami Yokota Hirai; Oliver Fiehn; Shigehiko Kanaya; Kazuki Saito
Journal:  PLoS One       Date:  2009-10-16       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.